136 related articles for article (PubMed ID: 36893819)
41. [Total skin electron therapy of mycosis fungoides and the Sézary syndrome].
Herbst M; Müller R
Hautarzt; 1984 Jan; 35(1):16-21. PubMed ID: 6423569
[TBL] [Abstract][Full Text] [Related]
42. Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
Foss FM; Ihde DC; Linnoila IR; Fischmann AB; Schechter GP; Cotelingam JD; Steinberg SM; Ghosh BC; Stocker JL; Bastian A
J Clin Oncol; 1994 Oct; 12(10):2051-9. PubMed ID: 7931473
[TBL] [Abstract][Full Text] [Related]
43. A prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides.
Kamstrup MR; Specht L; Skovgaard GL; Gniadecki R
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1204-7. PubMed ID: 18207669
[TBL] [Abstract][Full Text] [Related]
44. [Whole-skin electron therapy: a therapeutic concept for mycosis fungoides and Sézary syndrome. 2: Therapy].
Herbst M
Strahlentherapie; 1984 Mar; 160(3):154-8. PubMed ID: 6729855
[TBL] [Abstract][Full Text] [Related]
45. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
Yu JB; Khan AM; Jones GW; Reavely MM; Wilson LD
Am J Clin Oncol; 2009 Apr; 32(2):142-4. PubMed ID: 19307950
[TBL] [Abstract][Full Text] [Related]
46. Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment.
Jennings T; Duffy R; Gochoco A; Knoblauch K; Shi W; Alpdogan SO; Porcu P; Werner-Wasik M; Sahu J
Chin Clin Oncol; 2019 Feb; 8(1):13. PubMed ID: 30525753
[TBL] [Abstract][Full Text] [Related]
47. Literature review of clinical results of total skin electron irradiation (TSEBT) of mycosis fungoides in adults.
Moraes FY; Carvalho Hde A; Hanna SA; Silva JL; Marta GN
Rep Pract Oncol Radiother; 2014 Mar; 19(2):92-8. PubMed ID: 24936326
[TBL] [Abstract][Full Text] [Related]
48. Clinical severity measures and quality-of-life burden in patients with mycosis fungoides and Sézary syndrome: comparison of generic and dermatology-specific instruments.
Herbosa CM; Semenov YR; Rosenberg AR; Mehta-Shah N; Musiek AC
J Eur Acad Dermatol Venereol; 2020 May; 34(5):995-1003. PubMed ID: 31630443
[TBL] [Abstract][Full Text] [Related]
49. Allogeneic hematopoietic stem cell transplantation for heavily pretreated patients with mycosis fungoides and Sezary syndrome.
Cengiz Seval G; Sahin U; Bozdag SC; Yuksel MK; Topcuoglu P; Akay BN; Sanlı HE; Gurman G; Toprak SK; Ozcan M
Dermatol Ther; 2022 May; 35(5):e15447. PubMed ID: 35289037
[TBL] [Abstract][Full Text] [Related]
50. Helical Skin Radiation Therapy Including Total Skin Radiation Therapy Using Tomotherapy for Primary Cutaneous Lymphoma With Bone Marrow Suppression as a Related Adverse Event.
Kitaguchi M; Yamashita H; Takenaka R; Okuma K; Nawa K; Nakagawa K
Pract Radiat Oncol; 2021; 11(3):e308-e321. PubMed ID: 33440254
[TBL] [Abstract][Full Text] [Related]
51. Total skin electron beam therapy for primary cutaneous T-cell lymphomas: clinical characteristics and outcomes in a Mexican reference center.
Flores-Balcázar C; Urías-Arce DM; Charli-Joseph Y; De León-Alfaro MA; Pérez-Álvarez SI; Ramos-Prudencio R
Rep Pract Oncol Radiother; 2020; 25(4):562-567. PubMed ID: 32494229
[TBL] [Abstract][Full Text] [Related]
52. Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity.
Papadavid E; Kapniari E; Pappa V; Nikolaou V; Iliakis T; Dalamaga M; Jonak C; Porkert S; Engelina S; Quaglino P; Ortiz-Romero PL; Vico C; Cozzio A; Dimitriou F; Guiron R; Guenova E; Hodak E; Bagot M; Scarisbrick J
Br J Dermatol; 2021 Nov; 185(5):1035-1044. PubMed ID: 34137025
[TBL] [Abstract][Full Text] [Related]
53. Total skin electron irradiation therapy in mycosis fungoides using high-dose rate mode: a preliminary experience.
Parida DK; Verma KK; Chander S; Joshi RC; Rath GK
Int J Dermatol; 2005 Oct; 44(10):828-30. PubMed ID: 16207183
[TBL] [Abstract][Full Text] [Related]
54. Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
Foss FM; Ihde DC; Breneman DL; Phelps RM; Fischmann AB; Schechter GP; Linnoila I; Breneman JC; Cotelingam JD; Ghosh BC
J Clin Oncol; 1992 Dec; 10(12):1907-13. PubMed ID: 1453206
[TBL] [Abstract][Full Text] [Related]
55. Low-Dose Total Skin Electron Beam Therapy Combined With Mogamulizumab for Refractory Mycosis Fungoides and Sézary Syndrome.
Fong S; Hong EK; Khodadoust MS; Li S; Hoppe RT; Kim YH; Hiniker SM
Adv Radiat Oncol; 2021; 6(3):100629. PubMed ID: 33748543
[TBL] [Abstract][Full Text] [Related]
56. Total Skin Electron Beam Therapy with Rotary Dual Technique as Palliative Treatment for Mycosis Fungoides.
Piotrowski T; Fundowicz M; Pawlaczyk M
In Vivo; 2018; 32(3):517-522. PubMed ID: 29695554
[TBL] [Abstract][Full Text] [Related]
57. Total skin electron irradiation in mycosis fungoides dose and fractionation considerations.
Rosenblatt E; Kuten A; Leviov M; Cederbaum M
Leuk Lymphoma; 1998 Jun; 30(1-2):143-51. PubMed ID: 9669684
[TBL] [Abstract][Full Text] [Related]
58. Total Skin Electron Beam Therapy as Part of Multimodal Treatment Strategies for Primary Cutaneous T-Cell Lymphoma.
Elsayad K; Susek KH; Eich HT
Oncol Res Treat; 2017; 40(5):244-252. PubMed ID: 28448985
[TBL] [Abstract][Full Text] [Related]
59. The Results of Low-Dose Total Skin Electron Beam Radiation Therapy (TSEB) in Patients With Mycosis Fungoides From the UK Cutaneous Lymphoma Group.
Morris S; Scarisbrick J; Frew J; Irwin C; Grieve R; Humber C; Kuciejewska A; Bayne S; Weatherhead S; Child F; Wain M; Whittaker S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):627-633. PubMed ID: 28843374
[TBL] [Abstract][Full Text] [Related]
60. Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real-world French study.
Beylot-Barry M; Quereux G; Nardin C; Duval-Modeste AB; Dereure O; Dalac-Rat S; Dobos G; Pham-Ledard A; Ram-Wolff C; D'Incan M; Grange F; Braniste V; Bagot M
J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1777-1784. PubMed ID: 37113040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
